Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.9300 (1.4%) ($23.2400 - $24.2200) on Mon. Jun. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 49 | Latest Price | $23.9300(1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.065% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-3%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
Resistance Level | $24 | 5 Day Moving Average | $23.73(0.84%) | 10 Day Moving Average | $23.88(0.21%) | 20 Day Moving Average | $24(-0.29%) | To recent high | -3.6% | To recent low | 72.2% | Market Cap | $3.271b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |